Slower clearance of human SAA1.5 in mice: Implications for allele specific variation of SAA concentration in human

References

• Benson M D. Amyloidosis. The Metabolic Basis of Inherited Disease, 7ed, C R Scriver, A L Beaudet, W S Sly, D V Valle. McGraw-Hill, New York 1995; 4159–4191
   Google Scholar
• Husby G, Marhaug G, Dowton B, Sletten K, Sipe J D. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid: Int J Exp Clin Invest 1994; 1: 119–137
   Web of Science ®Google Scholar
• Jensen L E, Whitehead A S. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J 1998; 334: 489–503
   PubMed Web of Science ®Google Scholar
• Betts J C, Edbrooke M R, Thakker R V, Woo P. The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatome cells. Scand J Immunol 1991; 34: 471–482
   PubMed Web of Science ®Google Scholar
• Strachan A F, de Beer F C, van der Westhuyzen D R, Coetzee G A. Identification of three isoform pattertis of human serum amyloid A protein. Biochem J, 250: 203–207
   PubMedGoogle Scholar
• Liepnieks J J, Kluve-Beckerman Band Benson M D. Characterization of amyloid A protein in human secondary amyloidosis. The predominant deposition of serum amyloid A1. Biochim Biophys Acta 1995; 1270: 81–86
   PubMed Web of Science ®Google Scholar
• Sipe JD and Committee. Revised nomenclature for serum amyloid A (SAA). Amyloid:Int J Clin Exp Invest 1999; 6: 67–70
   PubMedGoogle Scholar
• Baba S, Masago S A, Takahashi T, Kasama T, Sugimura H, Tsugane S, Tsutsui Y, Shirasawa H. A novel alleic variant of serum amyloid A. SAAlg: Genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic amyloidosis. Hum Mol Genet 1995; 4: 1083–1087
   PubMed Web of Science ®Google Scholar
• Yamada T. Analysis of serum amyloid Al exon 4 polymorphism in Japanese population. Amyloid: Int J Clin Exp Invest 2000; 7: 118–120
   PubMed Web of Science ®Google Scholar
• Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, Nishinarita M, Uchida S, Nakajima A, Kim S Y, Chen C L, Kamatani N. Influence of genotypes at SAAl and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis. Hum Genet 1999; 105: 360–366
   PubMed Web of Science ®Google Scholar
• Yamada T, Okuda Y, Takasugi K, Itoh K, Igari J. Relative serum amyloid A (SAA) values: the influence of SAAl genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis. Ann Rheum Dis 2001; 60: 124–127
   PubMed Web of Science ®Google Scholar
• Yamada T, Wada A, Itoh Y, Itoh K. Serum amyloid Al alleles and plasma concentration of serum amyloid A. Amyloid: Int J Clin Exp Invest 1999; 6: 199–204
   PubMed Web of Science ®Google Scholar
• Yamada T, Kluve-Beckerman B, Liepnieks J J, Benson M D. Fibril formation from recombinant human serum amyloid A. Biochim Biophys Acta 1994; 1226: 323–329
   PubMed Web of Science ®Google Scholar
• Murrell J R, Schoner R G, Liepnieks J J, Rosen H N, Moses A C, Benson M D. Production and functional analysis of normal and variant recombinant human transthyretin proteins. J Biol Chem 1992; 267: 16595–16600
   PubMed Web of Science ®Google Scholar
• Yamada T, Wada A, Itoh K, Igari J. Serum amyloid A secretion from monocytic leukaemia cell line THP-1 and cultured human peripheral monocytes. Scand J Immunol 2000; 52: 7–12
   PubMed Web of Science ®Google Scholar
• Ancsin J B, Kisilevsky R. Laminin interactions with the apoproteins of acute phase HDL: preliminary mapping of the laminin binding site on serum amyloid A. Amyloid: Int J Clin Exp Invest 1999; 6: 37–47
   PubMed Web of Science ®Google Scholar
• Benson M D, Kluve-Beckerman B, Liepnieks J J, Murrell J R, Hanes D, Uemichi T. Metabo lism of amyloid proteins. Ciba Found Symp 1996; 199: 104–118
   PubMedGoogle Scholar
• Kluve-Beckerman B, Yamada T, Hardwick J, Liepnieks J J, Benson M D. Differential plasma clearance of murine acute-phase serum amyloid A proteins SAAl and SAA2. Biochem J 1997; 322: 663–669
   PubMed Web of Science ®Google Scholar
• Booth D R, Booth S E, Gillmore J D, Hawkins P N, Pepys M B. SAAl alleles as risk factors in reactive systemic amyloidosis. Amyloid:Int J Clin Exp Invest 1985; 5: 262–265
   Google Scholar
• Yamada T, Okuda Y, Takasugi K, Wang L, Marks D, Benson M, Kluve-Beckerman B. An allele of serum amyloid Al associated with amyloidosis in both Japanese and Caucasians. Amyloid: J Protein Folding Disord 2003; 10: 7–11
   PubMed Web of Science ®Google Scholar
• Wada A, Yamada T, Itoh K, Igari J. No significant influence of serum amyloid AI genotypes on serum lip-ids or HDL clearance. Rinsho Byori. 2000; 48: 174–177, (Japanese and the English abstract)
   PubMedGoogle Scholar